KATE vs Navina
Mednition's only funding round on Tracxn is a $10M Series A led by Concord Health Partners, announced in 2019. KATE is sold to emergency departments, and the vendor says it fits an existing EMR with zero workflow changes. Its homepage names no EMR.
Navina names athenahealth, Epic and Veradigm on its homepage and is built for primary care groups on value-based contracts. The vendor shows Privia Health and Agilon Health logos and lists HIPAA, SOC 2 and ISO 27001 badges. The Series C was $55M in March 2025. KLAS comments run mixed, with a VP calling risk adjustment strong but mostly Medicare-focused and a director saying support overpromises. The vendor-published Phyx report claims 40% less chart review time on complex visits and 92% trust in HCC suggestions, and it is not peer reviewed. Navina's risk adjustment and care-gap work sits in primary care value-based contracts and KATE's triage work in the ED, so each tool has its own buyer.
Decision support · Reviewed November 2, 2026
When to pick each one
KATE
- Sepsis risk flag aimed at emergency departments
- Vendor says it runs with zero workflow changes
Navina
- Names athenahealth, Epic and Veradigm integrations
- HIPAA, SOC 2 and ISO 27001 badges on homepage
- HCC suggestions at the visit for risk-adjusted contracts
Score
Each row shows points earned of points available under the published rubric.
KATE
12of 100
Navina
36of 100
| Dimension | KATE | Navina | Difference |
|---|---|---|---|
| FDA clearance | 0 / 12 | 0 / 12 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 10 / 10 | -10 |
| EHR integrations (count) | 0 / 5.6 | 1.7 / 5.6 | -1.7 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 3.4 / 4.8 | -3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 0 / 21 | 0 / 21 | 0 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 8.4 / 12 | -5.4 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 6 / 6 | 6 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
KATE
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Navina
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
KATE
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Navina
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | KATE | Navina |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | athenahealth, Epic, Veradigm |
| Founded | 2014 | 2018 |
| HQ | US | n/a |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.